Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$192.5 - $216.35 $45,237 - $50,842
235 Added 18.8%
1,485 $302,000
Q1 2024

May 07, 2024

SELL
$209.01 - $232.56 $418 - $465
-2 Reduced 0.16%
1,250 $273,000
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $20,559 - $23,638
104 Added 9.06%
1,252 $284,000
Q3 2023

Oct 30, 2023

BUY
$201.05 - $221.7 $230,805 - $254,511
1,148 New
1,148 $230,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Choate Investment Advisors Portfolio

Follow Choate Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Choate Investment Advisors with notifications on news.